![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|23|32|4862-4892
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.23, Iss.32, 2017-12, pp. : 4862-4892
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lentiviral Vectors for Anti-Tumor Immunotherapy
Current Gene Therapy, Vol. 8, Iss. 6, 2008-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors
Current Cancer Drug Targets, Vol. 5, Iss. 7, 2005-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antagonists of IAP Proteins: Novel Anti-Tumor Agents
Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-01 ,pp. :